Lv4
710 积分 2024-09-21 加入
Comparison of first line chemotherapy regimens for advanced soft tissue sarcoma: a network meta-analysis
7天前
已完结
Efficacy and safety of concomitant 177Lu-DOTATATE and low-dose capecitabine in advanced medullary thyroid carcinoma: a single-centre experience
7天前
已完结
Immunohistochemical study of fibroblast activation protein and α-smooth muscle actin expression and distribution in triple-negative breast cancer
8天前
已完结
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
9天前
已完结
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
12天前
已完结
Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer
14天前
已完结
Use of Capecitabine in Refractory Metastatic Medullary Thyroid Carcinoma
14天前
已完结
Novel treatment of medullary thyroid cancer
14天前
已完结
Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal
23天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
28天前
已完结
皖公网安备34019202002308
